Establishment Labs Holdings Inc (ESTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) has a cash flow conversion efficiency ratio of -0.292x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.31 Million) by net assets ($14.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ESTA equity financing ratio to measure how much of total assets are equity-financed.
Establishment Labs Holdings Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Establishment Labs Holdings Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Establishment Labs Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Establishment Labs Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elite Advanced Laser Corp
TW:3450
|
0.073x |
|
Orbia Advance Corporation S.A.B. de C.V
F:4FZ
|
0.134x |
|
John Wiley & Sons
NYSE:WLY
|
0.240x |
|
Genting Bhd
KLSE:3182
|
0.082x |
|
Banco do Nordeste do Brasil S.A
SA:BNBR3
|
-0.200x |
|
Jenoptik AG
F:JEN
|
0.054x |
|
COSCO SHIPPING Energy Transportation Co. Ltd
F:HIFH
|
0.072x |
|
Aether Industries Limited
NSE:AETHER
|
0.047x |
Annual Cash Flow Conversion Efficiency for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Establishment Labs Holdings Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Establishment Labs Holdings Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.55 Million | $-50.89 Million | -2.161x | -96.10% |
| 2024-12-31 | $53.09 Million | $-58.52 Million | -1.102x | +77.10% |
| 2023-12-31 | $18.39 Million | $-88.51 Million | -4.812x | -175.50% |
| 2022-12-31 | $-8.19 Million | $-52.17 Million | 6.373x | +1274.55% |
| 2021-12-31 | $50.74 Million | $-27.53 Million | -0.543x | -225.14% |
| 2020-12-31 | $74.96 Million | $-12.51 Million | -0.167x | +77.95% |
| 2019-12-31 | $39.61 Million | $-29.98 Million | -0.757x | -55.21% |
| 2018-12-31 | $69.48 Million | $-33.88 Million | -0.488x | -107.65% |
| 2017-12-31 | $-5.01 Million | $-31.97 Million | 6.377x | +1081.74% |
| 2016-12-31 | $-26.43 Million | $-14.27 Million | 0.540x | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more